Sree Roy, Author at Sleep Review

Harmony Biosciences Is Evaluating Pitolisant For Excessive Daytime Sleepiness in Patients with Prader-Willi Syndrome

Dec 21, 2020 |

The randomized, double-blind, placebo-controlled study is designed to assess the safety and efficacy of pitolisant in patients with PWS ages 6 to 65.

Here’s What 12,000 Respondents in 6 Countries Say About Their Sleep During the Pandemic

Dec 18, 2020 |

Thailand was revealed as the nation that was most sleep deprived, with half of respondents claiming they were definitely sleep deprived, followed by Germany, the US, UK, Italy, and Spain.

Digital CBT Is Most Cost Effective Option for Poor Sleep, Finds New Study

Dec 17, 2020 |

The study examined the cost effectiveness of digital CBT over a six-month period and measured the direct and indirect costs of insomnia.

Sleep Apnea Therapy Company Vivos Goes Public

Dec 17, 2020 |

The aggregate gross proceeds to Vivos from the public offering was $24.15 million prior to deducting underwriting discounts, commissions, and other estimated offering expenses.

Author: Sree Roy

Harmony Biosciences Is Evaluating Pitolisant For Excessive Daytime Sleepiness in Patients with Prader-Willi Syndrome

Here’s What 12,000 Respondents in 6 Countries Say About Their Sleep During the Pandemic

Digital CBT Is Most Cost Effective Option for Poor Sleep, Finds New Study

This investment and our merger with Ebb will help to accelerate growth into new spaces for consumers, meeting them where they are in the journey, with solutions for the bedroom, and on-the-go resources to help coach them along the way

Sleep Apnea Therapy Company Vivos Goes Public

Sleep Review

Our Parent Company

Key Resources

Helpful Links